Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Triple inactivated vaccine used for porcine circovirus-3, porcine parvovirus and swine influenza and preparation method thereof

A technology for porcine circovirus and parvovirus, applied in biochemical equipment and methods, vaccines, viruses, etc., can solve the problems of high cost, poor prevention and control effect, and large immunization workload, and achieve high cost and convenient immunization. , the effect of high titer content

Active Publication Date: 2019-04-02
哈药集团生物疫苗有限公司
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, for these kinds of diseases, each vaccine needs to be injected separately. The workload of immunization is heavy and the cost is high, resulting in poor prevention and control effect, which needs to be improved urgently.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Triple inactivated vaccine used for porcine circovirus-3, porcine parvovirus and swine influenza and preparation method thereof
  • Triple inactivated vaccine used for porcine circovirus-3, porcine parvovirus and swine influenza and preparation method thereof
  • Triple inactivated vaccine used for porcine circovirus-3, porcine parvovirus and swine influenza and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Embodiment 1 expresses the preparation of PCV3 type Cap protein recombinant baculovirus vector, PPV and S IV (H3N2 subtype) triple inactivated vaccine

[0029] 1 Obtaining Antigen Solution of Porcine Circovirus Type 3 Recombinant Baculovirus

[0030] 1.1 Construction of recombinant baculovirus vector expressing PCV3 type Cap protein

[0031] Use the primers in the following table 1 to amplify the Cap protein gene (ORF2) from the PCV3 strain DNA extracted from the suspected porcine circovirus disease material in Jilin, and after recovery, digest the recovery product with BamH I and Xho I respectively , and then ligated with the same digested plasmid pOET1, the obtained recombinant plasmid was identified by restriction enzyme digestion and PCR, and it was determined that the recombinant plasmid pOET1-ORF2-ChS-1 was obtained. Sf9 insect cells (Invitrogen) were co-transfected with insect virus DNA (flashBACPrime) from Oxford Expression Technologies, UK, and transfer plasmi...

Embodiment 2 3

[0074] The preparation of embodiment 2 triple inactivated vaccines

[0075] The preparation of porcine circovirus type 3 recombinant baculovirus antigen solution, porcine parvovirus L strain antigen solution and swine influenza H3N2 subtype HLJ strain antigen solution was prepared according to the method in Example 1, and the pig circovirus that passed the inactivation test was Virus type 3 recombinant baculovirus ChS-1 strain Cap protein antigen solution, PPV L strain antigen solution and SIV H3N2 subtype HLJ strain antigen solution were prepared in a ratio of 1:1:1 to prepare a triple inactivated vaccine, and the rest were mixed with Example 1 is the same.

Embodiment 3 3

[0076] The preparation of embodiment 3 triple inactivated vaccines

[0077] The preparation of porcine circovirus type 3 recombinant baculovirus antigen solution, porcine parvovirus L strain antigen solution and swine influenza H3N2 subtype HLJ strain antigen solution was prepared according to the method in Example 1, and the pig circovirus that passed the inactivation test was Virus type 3 recombinant baculovirus ChS-1 strain Cap protein antigen solution, PPV L strain antigen solution and SIV H3N2 subtype HLJ strain antigen solution were prepared in a ratio of 2:1:1 to prepare a triple inactivated vaccine, and the rest were mixed with Example 1 is the same.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Cell densityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a triple inactivated vaccine used for porcine circovirus-3, porcine parvovirus and swine influenza and a preparation method thereof. The present invention first discloses the triple inactivated vaccine for the prevention and treatment of porcine circovirus syndrome, porcine parvovirus disease and swine influenza. The vaccine comprises: an inactivated antigenic solution of porcine circovirus-3 Cap protein, an inactivated antigenic solution of porcine parvovirus, an antigenic solution of porcine influenza virus and a vaccine adjuvant. The invention further discloses a method for preparing the triple inactivated vaccine, and the method comprises: mixing inactivated antigenic solutions together, uniformly mixing the mixed solutions with the vaccine adjuvant, and performing emulsification. The preparation method of the triple inactivated vaccine of the invention is simple, the vaccine has a high titer content and is convenient and quick for immunization. The triple vaccine provided by the invention has better safety, achieves "one shot with three preventions", avoids adverse reactions caused by multiple vaccination, reduces breeding cost, reduces the immunizationtimes, and can also effectively reduce the stress response of animals and improve the welfare treatment for animals.

Description

technical field [0001] The present invention relates to the triple inactivated vaccine of circovirus type 3, porcine parvovirus and swine influenza (H3N2 subtype), and the present invention further relates to the preparation method of the triple inactivated vaccine and its application in the prevention and treatment of PMWS syndrome, porcine parvovirus disease and The application in swine flu belongs to the field of preparation and application of triple inactivated vaccine of porcine circovirus type 3, porcine parvovirus and swine flu. Background technique [0002] Porcine circovirus (PCV) belongs to the genus Circovirus of the Circoviridae family. It is a small, non-encapsulated, covalently closed, circular, single-stranded DNA virus with an average particle diameter of 17nm. Smallest animal virus ever discovered. Currently, PCV can be divided into 3 genotypes, namely PCV-1, PCV-2 and PCV3. PCV-1 is a non-pathogenic PCV, and both PCV-2 and PCV-3 are pathogenic to pigs and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/12A61K39/23A61K39/145A61P31/20A61P31/16
CPCA61K39/12A61P31/16A61P31/20A61K2039/5256A61K2039/70C12N2760/16134C12N2750/10034C12N2750/14334
Inventor 张凤强张智明柴华刘洪斌孙心孙晓峰方超杨大伟刘旭毕德峰
Owner 哈药集团生物疫苗有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com